"Cattle producers who aren’t using modified-live virus (MLV) vaccines on their operations can be missing out on profits and reproductive protection," said Tim Dawson, DVM, a Cheyenne, Wyoming, large animal veterinarian. To him, the safety, efficacy against reproductive diseases and duration of immunity offered by MLV vaccines is demonstrated in research and his 30 years of practice.
"Some 99 percent of my clients with 70,000 head of cattle are using a MLV vaccine program, and our success has been very good," Dawson said. "The MLV vaccine program sets cattle up to have an immunity to disease, and it helps them stay efficient moving into the next production phase."
Unlike most killed vaccines, MLV vaccines offer reproductive and fetal protection, so clinical disease can be prevented in both the cow and the calf. That’s good for business — ensuring cows get bred and stay pregnant.
Dawson encourages producers to work with their veterinarian to fully understand the label instructions for MLV vaccines. Not following the label as instructed has consequences, he explained, but the reproductive rewards from correctly implementing MLV vaccines are second to none.
"Consider the efficacy and duration of immunity," Dawson said. "Today, we only need to treat maybe half a percent of animals previously vaccinated with MLV vaccines. That helps manpower, performance, value, and it’s what we’ve come to expect by integrating MLV vaccines into these cow herds."
Hear more from Dawson about implementing a MLV vaccination program against common viral diseases, including bovine viral diarrhea (BVD). Ask a veterinarian about reproductive disease protection supported by a Fetal Protection (FP) Guarantee* with the BOVI-SHIELD GOLD FP®** and PREGGUARD GOLD FP** vaccine lines.
*The Zoetis 100% BVD PI-Free Guarantee and the IBR Abortion Guarantee will be administered through Zoetis VMIPS (Veterinary Medical Information and Product Support) at 800-366-5288. Proof of purchase is required. Calves born to BVD PI-positive cows or heifers do not qualify for the guarantee. This guarantee does not apply to, and Zoetis shall not be liable for, any (x) damages caused as a result of the improper handling, misuse or abuse of the vaccines that are the subject of this guarantee, or the willful misconduct or negligence of any third party, or (y) any indirect, punitive, special, incidental or consequential damages. Zoetis reserves the right to modify or cancel the terms and conditions of this guarantee.
**LABEL INDICATIONS: Do not use in pregnant cattle (abortions can result) unless they were vaccinated, according to label directions, with any BOVI-SHIELD GOLD FP or PREGGUARD GOLD FP vaccine prebreeding initially and within 12 months thereafter. Do not use in calves nursing pregnant cows unless their dams were vaccinated within the past 12 months as described above. To help ensure safety in pregnant cattle, heifers must receive at least 2 doses of any BOVI-SHIELD GOLD FP or PREGGUARD GOLD FP vaccine with the second dose administered approximately 30 days prebreeding.
Zoetis (zo-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenues of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 28 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit https://www.zoetisus.com.